Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

GATA3 Gene - a Potential New Biomarker Associated with Adverse Outcomes in ALK1-Negative Anaplastic Large Cell Lymphoma: Preliminary Results from a Retrospective Cohort of 80 South American Cases of Nodal Peripheral T Lymphoma

Luis Alberto de Padua Covas Lage, MD PhD, Claudio Vinicius Brito, MD, Debora Levy, MSc, PhD, Hebert Fabricio Culler, MSc, PhD, Samuel Campanelli Freitas Couto, PhD, Lucas BO Alves, PhD, Maria C Zerbini, MD PhD Prof MD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-140833

Published: 2020

Journal Articles

Overexpression of the OCT-1 Gene Is a Biomarker Associated with Poor Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) - Data from a Retrospective Cohort from Latin America: Defining a Very High-Risk Clinical-Molecular Subgroup

Luis Alberto de Padua Covas Lage, MD PhD, Gisele Rodrigues Gouveia, PhD, Suzete Cleusa Ferreira, PhD, Sheila Aparecida Coelho de Siqueira, MD PhD, Abrahão Elias Hallack Neto, MD PhD, Renata Oliveira Costa, MDPhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-142715

Published: 2020

Journal Articles

Clinical, Laboratory, and Genetic Features of Erdheim-Chester Disease Patients from Two Reference Centers in a Developing Country

Antonio Adolfo Guerra Soares Brandão, MD, Giancarlo Fatobene, MD, Andre Abdo, MD, Luis Alberto de Padua Covas Lage, MD PhD, Israel Bendit, MD PhD, Luciana Nardinelli, MSc, Sheila Aparecida Coelho de Siqueira, MD PhD, Debora Levy, MSc, PhD, Juliana Pereira, MD PhD, Eduardo M Rego, MDPhD, Vanderson Rocha, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-142617

Published: 2020

Journal Articles

Splenic Marginal Zone Lymphoma (SMZL) - Outcomes, Prognostic Factors and Risk-Adapted Therapy in Resource-Poor Settings: Data from a Latin American Retrospective Cohort

Luis Alberto de Padua Covas Lage, MD PhD, Felipe Faganelli Caboclo dos Santos, MD, Kasys Meira Gervatauskas, MD, Debora Levy, MSc, PhD, Frederico Rafael Moreira, PhD, Samuel Campanelli Freitas Couto, PhD, Hebert Fabricio Culler, MSc, PhD, Renata Oliveira Costa, MDPhD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140807

Published: 2020

Journal Articles

Adult T-Cell Leukemia/Lymphoma: A Cohort of 41 Cases Recorded in the Brazilian T-Cell Project

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142818

Published: 2020

Journal Articles

Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results

Pierluigi Porcu, MD, Bradley Haverkos, MD MPH, MS, Onder Alpdogan, MD, Robert Baiocchi, MD PhD, Jonathan E Brammer, MD, Tatyana A. Feldman, MD, Marcelo Capra, MD PhD, Elizabeth A Brem, MD, Phillip Scheinberg, MD, Juliana Pereira, MD PhD, Leyla Shune, MD, Afton Katkov, MSc, Robert McRae, Lisa Rojkjaer, MD, Ivor Royston, MD, Douglas V. Faller, MD PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-140843

Published: 2020

Journal Articles

Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

Blood (2019) 134 (Supplement_1): 465.

https://doi.org/10.1182/blood-2019-132004

Published: 2019

Journal Articles

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

Lidiane Inês Da Rosa, MD, Wellington Fernandes da Silva, MD, Andre Abdo, MD, Eduardo M Rego, MD PhD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2019) 134 (Supplement_1): 5284.

https://doi.org/10.1182/blood-2019-126307

Published: 2019

Journal Articles

Outcomes of HIV-Associated Burkitt Lymphoma in Brazil: High Treatment Toxicity and Refractoriness Rates - a Multicenter Cohort Study

Wellington F Silva, MD, Pedro Marques Garibaldi, MD, Lidiane Inês Da Rosa, MD, Marcelo Bellesso, MD, Diego V Clé, MD PhD, Marcia Torresan Delamain, MD, Eduardo M Rego, MD PhD, Juliana Pereira, MD PhD, Vanderson Rocha, MD PhD

Blood (2019) 134 (Supplement_1): 1616.

https://doi.org/10.1182/blood-2019-129627

Published: 2019

Journal Articles

Clinical Outcome and Characteristics of Patients with Primary Central Nervous System Lymphomas (PCNSL) in a Brazilian Population

Diego Reis, Tatiane Ishida, MD, Luis A P C Lage, MD MSc, PhD, Hebert F Culler, MSc, PhD, Renata O Costa, MD PhD Prof MD, Maria C Zerbini, MD PhD Prof MD, Debora Levy, MSc, PhD, Vanderson Rocha, MD MSc, PhD Prof MD, Juliana Pereira, MD PhD Prof MD

Blood (2017) 130 (Supplement 1): 5631.

https://doi.org/10.1182/blood.V130.Suppl_1.5631.5631

Published: 2017

Journal Articles

Paraoxonases 1 and 2 (PON1 and 2) Polymorphisms in Diffuse Large B-Cell Lymphoma (DLBCL): Correlation with Clinical Outcomes

Debora Levy, MSc, PhD, Diego Reis, Karolline Santana da Silva, MSc, Luis A P C Lage, MD MSc, PhD, Bruno Sini, Luciana M. F. Maseli, Vanderson Rocha, MD MSc, PhD Prof MD, Juliana Pereira, MD PhD Prof MD, Sergio P Bydlowski, MD MSc, PhD Prof MD

Blood (2017) 130 (Supplement 1): 5130.

https://doi.org/10.1182/blood.V130.Suppl_1.5130.5130

Published: 2017

Journal Articles

Risk Factors for Early Mortality in Fragile Patients with Non-Hodgkin Lymphoma at Diagnosis Who Need Hospitalization in a Developing Country

Ivan de Carvalho Valente Barbosa, Marcelo Bellesso, MD, Debora Levy, Juliana Pereira, MD PhD, Vanderson Rocha, MD PhD

Blood (2016) 128 (22): 5407.

https://doi.org/10.1182/blood.V128.22.5407.5407

Published: 2016

Journal Articles

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Blood (2016) 128 (22): 4159.

https://doi.org/10.1182/blood.V128.22.4159.4159

Published: 2016

Journal Articles

Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University

Ana Costa Cordeiro, MD, Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, Debora Levy, Juliana Pereira, MD PhD

Blood (2015) 126 (23): 5091.

https://doi.org/10.1182/blood.V126.23.5091.5091

Published: 2015

Journal Articles

First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)

Blood (2015) 126 (23): 341.

https://doi.org/10.1182/blood.V126.23.341.341

Published: 2015

Journal Articles

A New Accurate and Reproducible Method to Assess Telomere Length by Flow-FISH.

Graciela Aparecida Brocardo, Carla Rosa Teixeira de Godoy, Débora Levy, PhD, Lis Vilela de Almeida, Gracia Martinez, MD, PhD, Dalton Chamone, MD, PhD, Juliana Pereira, MD, PhD

Blood (2009) 114 (22): 4719.

https://doi.org/10.1182/blood.V114.22.4719.4719

Published: 2009

Journal Articles

FCγRIIa Polymorphism Is Not Associated with Overall Response in Diffuse Large B-Cell Lymphoma Treated with Rituximab.

Debora Levy, PhD, Pamela Oliveira-Souza,, Marcelo Bellesso, MD, Master, Felipe Vieira Rodrigues Maciel, MD, Juliana Pereira, MD, PhD, Sergio Paulo Bydlowski, MD, PhD

Blood (2009) 114 (22): 4994.

https://doi.org/10.1182/blood.V114.22.4994.4994

Published: 2009

Journal Articles

The Utility of Positron Emission Tomography (PET) with 18Fluorodeoxyglucose (18F-FDG) Compared to Standard Procedures in Detecting Bone Marrow Infiltration in Diffuse Large B-Cell Lymphoma in Developing Countries.

Marcelo Bellesso, MD, Master, Renata Oliveira Costa, MD, Master, Flavia Dias Xavier, MD, José Claudio Meneguetti, MD, PhD, Felipe Vieira Rodrigues Maciel, MD, Daniel Salas Steinbaun, MD, Abrahao Elias Hallack-Neto, MD, PhD, Dalton Alencar Fisher Chamone, MD, PhD, Juliana Pereira, MD, PhD

Blood (2009) 114 (22): 5015.

https://doi.org/10.1182/blood.V114.22.5015.5015

Published: 2009

Journal Articles

Unexpected Monoclonal T Cell Line Derived From the Bone Marrow of a Multiple Myeloma Patient.

Debora Levy, PhD, Graciela Aparecida Brocardo, Carla Rosa Teixeira de Godoy, Camila da Cruz Gouveia Linardi, MD, Jorge Maria Ruiz, Gracia Martinez, MD, PhD, Adilson Ferreira Kleber, Durvanei Augusto Maria, PhD, Juliana Pereira, MD, PhD, Sergio Paulo Bydlowski, MD, PhD

Blood (2009) 114 (22): 4905.

https://doi.org/10.1182/blood.V114.22.4905.4905

Published: 2009

Journal Articles

Association of Genetic Polymorphisms of Glutatione-S-Transferase Genes and Overall Response/Clinical Features in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab.

Pamela Oliveira-Souza, Debora Levy, PhD, Hamen G Booij, Felipe Vieira Rodrigues Maciel, MD, Juliana Pereira, MD, PhD, Sergio Paulo Bydlowski, MD, PhD

Blood (2009) 114 (22): 1939.

https://doi.org/10.1182/blood.V114.22.1939.1939

Published: 2009

NARROW

GATA3 Gene - a Potential New Biomarker Associated with Adverse Outcomes in ALK1-Negative Anaplastic Large Cell Lymphoma: Preliminary Results from a Retrospective Cohort of 80 South American Cases of Nodal Peripheral T Lymphoma

Overexpression of the OCT-1 Gene Is a Biomarker Associated with Poor Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) - Data from a Retrospective Cohort from Latin America: Defining a Very High-Risk Clinical-Molecular Subgroup

Clinical, Laboratory, and Genetic Features of Erdheim-Chester Disease Patients from Two Reference Centers in a Developing Country

Splenic Marginal Zone Lymphoma (SMZL) - Outcomes, Prognostic Factors and Risk-Adapted Therapy in Resource-Poor Settings: Data from a Latin American Retrospective Cohort

Adult T-Cell Leukemia/Lymphoma: A Cohort of 41 Cases Recorded in the Brazilian T-Cell Project

Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

Outcomes of HIV-Associated Burkitt Lymphoma in Brazil: High Treatment Toxicity and Refractoriness Rates - a Multicenter Cohort Study

Clinical Outcome and Characteristics of Patients with Primary Central Nervous System Lymphomas (PCNSL) in a Brazilian Population

Paraoxonases 1 and 2 (PON1 and 2) Polymorphisms in Diffuse Large B-Cell Lymphoma (DLBCL): Correlation with Clinical Outcomes

Risk Factors for Early Mortality in Fragile Patients with Non-Hodgkin Lymphoma at Diagnosis Who Need Hospitalization in a Developing Country

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University

First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)

A New Accurate and Reproducible Method to Assess Telomere Length by Flow-FISH.

FCγRIIa Polymorphism Is Not Associated with Overall Response in Diffuse Large B-Cell Lymphoma Treated with Rituximab.

The Utility of Positron Emission Tomography (PET) with 18Fluorodeoxyglucose (18F-FDG) Compared to Standard Procedures in Detecting Bone Marrow Infiltration in Diffuse Large B-Cell Lymphoma in Developing Countries.

Unexpected Monoclonal T Cell Line Derived From the Bone Marrow of a Multiple Myeloma Patient.

Association of Genetic Polymorphisms of Glutatione-S-Transferase Genes and Overall Response/Clinical Features in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only